Antibodies that neutralize oxidized fats to protect bone health
Official title: Antibodies against Oxidized Phospholipids and Osteoporosis
Funded at Central Arkansas Veterans Hlthcare Sys · NIH-11264782 · Data updated 2026-11-12
This project will see if boosting natural antibodies that neutralize oxidized phospholipids can help prevent age-related bone loss and osteoporosis.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Central Arkansas Veterans Hlthcare Sys NIH-funded |
| Lab location | 1 site (North Little Rock, United States) |
| Project start | October 1, 2019 |
| Project end | December 31, 2027 |
| Funding year | 2026 |
| NIH project number | 5I01BX003901-07 |
| Project ID | NIH-11264782 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates would be older adults with osteoporosis or progressive age-related bone loss who are interested in novel biologic approaches to protect bone.
✕Less likely to help
People whose bone loss is due to unrelated genetic disorders, untreated hormonal imbalances, or conditions not driven by oxidized phospholipids may not benefit from this approach.
What this research studies
You can learn about a harmful type of oxidized fat (oxidized phospholipids) that damages bone-forming cells and may drive osteoporosis. In mice, increasing a natural antibody called E06 protected bone mass and increased bone formation, so researchers are working to raise those antibody levels either genetically or by injections. They are studying effects on bone cells, bone-building pathways (like Wnt signaling), and overall bone mass using cell studies and sequencing techniques. The work aims to turn those findings into approaches that could someday prevent or reverse bone loss in people.
Why it matters
Potential benefit: If successful, this work could lead to a new therapy that protects bone-forming cells and reduces fracture risk from osteoporosis.
How similar studies have gone: Related experiments showed increased bone mass in mice with higher E06 antibody levels, but translating this approach to humans is still new.
Where this research is happening
-
Central Arkansas Veterans Hlthcare Sys
North Little Rock, United States Active
Researchers
- Principal investigator: Ambrogini, Elena — Central Arkansas Veterans Hlthcare Sys
- Study coordinator: Ambrogini, Elena
Related research
Other NIH-funded projects on the same topics.
-
Or olive-oil derived compound to prevent bone loss in women
A safe, orally taken nutraceutical may help prevent osteoporosis in adult women by supporting bone formation and reducing bone loss.
-
When to stop, switch, or pause long-term osteoporosis medicines for older adults
This project looks at whether stopping, switching, or taking breaks from long-term osteoporosis drugs changes fracture risk and side effects for older adults.
-
Cortical Bone Mechanics Technology to better screen for osteoporosis
A new noninvasive test called CBMT uses ulnar flexural rigidity to predict fracture risk better than standard bone density tests, helping adults who may be at risk for osteoporosis.
-
Gene therapy for osteoporosis linked to ALDH2 deficiency in postmenopausal East Asian women
A gene therapy approach is being developed to reduce osteoporosis risk in postmenopausal East Asian women who have ALDH2 deficiency and drink alcohol.
-
Metabolomics clues to osteoporosis risk in diverse populations
A study using small molecules in blood samples to understand osteoporosis risk, with a focus on aging, ethnicity, and sex differences.
-
Single-Cell Study of Bone Cells to Understand Osteoporosis
Researchers will study individual bone-related cells from people to uncover why aging leads to weaker bones and higher fracture risk.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.